Pliant Therapeutics, Inc. (PLRX) KPIs and segments

PLRXNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30

$0.74−0.04 (-4.84%)

Close on Nov 12, 2026Market cap $45.82MP/E –Yield 0.00%

KPIs & segments

Operating metrics and segments that drive Pliant Therapeutics's business

Coming soon

This tab will track the numbers specific to Pliant Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?